In contrast, the network meta-analysis showed a trend toward PFS benefit for amiva-lazer-chemo but did not reach statistical significance, potentially due to limited sample sizes in both analyses.
← all excerpts
Efficacy and safety analysis of treatment in patients with EGFR-mutated advanced NSCLC who progressed on TKIs: a systematic review and meta-analysis.
1
—
—